12-71941600-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_173353.4(TPH2):c.122C>A(p.Ser41Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,613,904 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_173353.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPH2 | NM_173353.4 | c.122C>A | p.Ser41Tyr | missense_variant | 2/11 | ENST00000333850.4 | NP_775489.2 | |
TPH2 | XR_001748575.2 | n.264C>A | non_coding_transcript_exon_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPH2 | ENST00000333850.4 | c.122C>A | p.Ser41Tyr | missense_variant | 2/11 | 1 | NM_173353.4 | ENSP00000329093.3 | ||
TPH2 | ENST00000546576.1 | n.132C>A | non_coding_transcript_exon_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00105 AC: 160AN: 152102Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00209 AC: 525AN: 250984Hom.: 7 AF XY: 0.00195 AC XY: 264AN XY: 135648
GnomAD4 exome AF: 0.00110 AC: 1614AN: 1461684Hom.: 27 Cov.: 31 AF XY: 0.00110 AC XY: 800AN XY: 727146
GnomAD4 genome AF: 0.00106 AC: 161AN: 152220Hom.: 1 Cov.: 32 AF XY: 0.00124 AC XY: 92AN XY: 74430
ClinVar
Submissions by phenotype
Tryptophan 5-monooxygenase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Major depressive disorder;C2751802:Attention deficit-hyperactivity disorder, susceptibility to, 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 04, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at